← Back to all trials
Not Yet Recruiting
NCT05625958
Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
Conditions: Glaucoma, Open-Angle, Glaucoma, Narrow Angle
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 35
Sponsor: Ciliatech
Summary
The purpose of this study is to evaluate the safety and effectiveness of implanting a new version of an interposition supraciliary implant (SV22) as a stand-alone therapy for lowering intraocular pressure (IOP) in patients with primary open and narrow angle glaucoma who have failed at least one class of topical medical therapy
Eligibility Criteria
Inclusion Criteria:Diagnosis of POAG Schafer 1 to 4Medicated IOP ≥ 21naive of any prior glaucoma surgeryExclusion Criteria:Inflammatory, congenital, traumatic, neovascular, ICE syndrome, angle closure and Schaffer 1 and 2 glaucoma
Source: ClinicalTrials.gov (NCT05625958). StuddyBuddy aggregates publicly available trial information.
